Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label (mitapivat). Show all posts
Showing posts with label (mitapivat). Show all posts
Thursday, March 3, 2022

FDA Approves Pyrukynd (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency

›
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering therapies for genetically defined diseas...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.